What do systematic reviews say?

Intervention not reported

• Non‐vitamin K antagonist oral anticoagulants (NOACs) post‐percutaneous coronary intervention: a network meta‐analysis 2019 · Cochrane Headline outcomes only
  no estimate extracted
  1 study · 1389 participants
  Low

Intervention not reported

• Non‐vitamin K antagonist oral anticoagulants (NOACs) post‐percutaneous coronary intervention: a network meta‐analysis 2019 · Cochrane Headline outcomes only
  no estimate extracted
  1 study · 1399 participants
  Low

Intervention not reported

• Non‐vitamin K antagonist oral anticoagulants (NOACs) post‐percutaneous coronary intervention: a network meta‐analysis 2019 · Cochrane Headline outcomes only
  no estimate extracted
  1 study · 1962 participants
  Low

Intervention not reported

• Non‐vitamin K antagonist oral anticoagulants (NOACs) post‐percutaneous coronary intervention: a network meta‐analysis 2019 · Cochrane Headline outcomes only
  no estimate extracted
  1 study · 1527 participants
  Low

Intervention not reported

• Non‐vitamin K antagonist oral anticoagulants (NOACs) post‐percutaneous coronary intervention: a network meta‐analysis 2019 · Cochrane Headline outcomes only
  no estimate extracted
  1 study · 1399 participants
  Low

Intervention not reported

• Non‐vitamin K antagonist oral anticoagulants (NOACs) post‐percutaneous coronary intervention: a network meta‐analysis 2019 · Cochrane Headline outcomes only
  no estimate extracted
  2 studies · 4930 participants
  Moderate

Intervention not reported

• Non‐vitamin K antagonist oral anticoagulants (NOACs) post‐percutaneous coronary intervention: a network meta‐analysis 2019 · Cochrane Headline outcomes only
  no estimate extracted
  2 studies · 1542 participants
  Very low

Intervention not reported

• Non‐vitamin K antagonist oral anticoagulants (NOACs) post‐percutaneous coronary intervention: a network meta‐analysis 2019 · Cochrane Headline outcomes only
  no estimate extracted
  1 study · 1399 participants
  Low

Intervention not reported

• Non‐vitamin K antagonist oral anticoagulants (NOACs) post‐percutaneous coronary intervention: a network meta‐analysis 2019 · Cochrane Headline outcomes only
  no estimate extracted
  1 study · 1962 participants
  Low

Intervention not reported

• Non‐vitamin K antagonist oral anticoagulants (NOACs) post‐percutaneous coronary intervention: a network meta‐analysis 2019 · Cochrane Headline outcomes only
  no estimate extracted
  1 study · 1527 participants
  Low

Intervention not reported

• Non‐vitamin K antagonist oral anticoagulants (NOACs) post‐percutaneous coronary intervention: a network meta‐analysis 2019 · Cochrane Headline outcomes only
  no estimate extracted
  2 studies · 4930 participants
  Low

Transradial vs transfemoral approach

Transradial probably leads to lower short‐term NACE compared with transfemoral approach (moderate certainty).

• Transradial versus transfemoral approach for diagnostic coronary angiography and percutaneous coronary intervention in… 2018 · Cochrane Headline outcomes only
  RR 0.76 [0.61, 0.94]
  4 studies · 17133 participants
  Moderate

Transradial vs transfemoral approach

Transradial probably leads to lower short‐term cardiac death compared with transfemoral approach (moderate certainty).

• Transradial versus transfemoral approach for diagnostic coronary angiography and percutaneous coronary intervention in… 2018 · Cochrane Headline outcomes only
  RR 0.69 [0.54, 0.88]
  11 studies · 11170 participants
  Moderate

Transradial vs transfemoral approach

Transradial showed no clear difference in short‐term MI compared with transfemoral approach (high certainty).

• Transradial versus transfemoral approach for diagnostic coronary angiography and percutaneous coronary intervention in… 2018 · Cochrane Headline outcomes only
  RR 0.91 [0.81, 1.02]
  11 studies · 19430 participants
  High

Transradial vs transfemoral approach

Transradial probably leads to lower success of the procedure compared with transfemoral approach (moderate certainty).

• Transradial versus transfemoral approach for diagnostic coronary angiography and percutaneous coronary intervention in… 2018 · Cochrane Headline outcomes only
  RR 0.97 [0.96, 0.98]
  28 studies · 25920 participants
  Moderate

Transradial vs transfemoral approach

Transradial leads to lower short‐term all‐cause mortality compared with transfemoral approach (high certainty).

• Transradial versus transfemoral approach for diagnostic coronary angiography and percutaneous coronary intervention in… 2018 · Cochrane Headline outcomes only
  RR 0.77 [0.62, 0.95]
  10 studies · 18955 participants
  High

Transradial vs transfemoral approach

Transradial may leads to lower bleeding compared with transfemoral approach (low certainty).

• Transradial versus transfemoral approach for diagnostic coronary angiography and percutaneous coronary intervention in… 2018 · Cochrane Headline outcomes only
  RR 0.54 [0.4, 0.74]
  20 studies · 23043 participants
  Low

Transradial vs transfemoral approach

Transradial may leads to lower access site complications compared with transfemoral approach (low certainty).

• Transradial versus transfemoral approach for diagnostic coronary angiography and percutaneous coronary intervention in… 2018 · Cochrane Headline outcomes only
  RR 0.36 [0.22, 0.59]
  24 studies · 16112 participants
  Low

Xiongshao capsule (XSC) plus conventional western medicine (CWM) vs Western medicine

The review found no eligible studies for this question.

• Xiongshao for restenosis after percutaneous coronary intervention in patients with coronary heart disease 2013 · Cochrane Headline outcomes only
  no estimate extracted
  Studies not reported
  No studies found

Xiongshao capsule (XSC) plus conventional western medicine (CWM) vs conventional western medicine (CWM) plus placebo

Xiongshao capsule (XSC) plus conventional western medicine (CWM) leads to lower restenosis Coronary angiography compared with conventional western medicine (CWM) plus placebo (high certainty).

• Xiongshao for restenosis after percutaneous coronary intervention in patients with coronary heart disease 2013 · Cochrane Headline outcomes only
  RR 0.52 [0.33, 0.8]
  2 studies · 432 participants
  High